Aviance Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Aviance Capital Partners, LLC

$681 Million
Q2 2024

A detailed history of Aviance Capital Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 17,478 shares of GILD stock, worth $1.47 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

17,478

Previous 18,230 4.13%

Holding current value

$1.47 Million

Previous $1.34 Million 10.19%

% of portfolio

0.18%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $47,488 - $54,805	-752 Reduced 4.13%	17,478 $1.2 Million
Q1 2024 Apr 17, 2024	BUY	$71.58 - $87.29 $40,729 - $49,668	569 Added 3.22%	18,230 $1.34 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $32,898 - $37,307	-449 Reduced 2.48%	17,661 $1.43 Million
Q3 2023 Nov 06, 2023	SELL	$73.94 - $80.67 $36,822 - $40,173	-498 Reduced 2.68%	18,110 $1.36 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $34,888 - $39,795	459 Added 2.53%	18,608 $1.43 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $20,409 - $23,253	264 Added 1.48%	18,149 $1.51 Million
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $76,778 - $110,227	1,232 Added 7.4%	17,885 $1.54 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $18,040 - $20,607	303 Added 1.85%	16,653 $1.03 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $216,854 - $244,242	3,757 Added 29.83%	16,350 $1.01 Million
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $134,084 - $168,022	-2,315 Reduced 15.53%	12,593 $749,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $18,425 - $20,913	-284 Reduced 1.87%	14,908 $1.08 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $37,364 - $40,312	-552 Reduced 3.51%	15,192 $1.06 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $58,836 - $64,287	-927 Reduced 5.56%	15,744 $1.08 Million
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $19,860 - $22,660	-331 Reduced 1.95%	16,671 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $169,950 - $193,650	-3,000 Reduced 15.0%	17,002 $991,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $44,028 - $55,358	-709 Reduced 3.42%	20,002 $1.26 Million
Q2 2020 Jul 24, 2020	BUY	$72.34 - $84.0 $151,335 - $175,728	2,092 Added 11.24%	20,711 $1.59 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $52,296 - $66,983	-835 Reduced 4.29%	18,619 $1.39 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $3,635 - $3,999	59 Added 0.3%	19,454 $1.26 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $145,273 - $160,356	-2,324 Reduced 10.7%	19,395 $1.23 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $104,498 - $117,182	1,689 Added 8.43%	21,719 $1.47 Million
Q1 2019 May 01, 2019	SELL	$62.53 - $70.05 $3,751 - $4,203	-60 Reduced 0.3%	20,030 $1.3 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $200,871 - $262,122	-3,318 Reduced 14.17%	20,090 $1.26 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $852,152 - $943,488	11,955 Added 104.38%	23,408 $1.81 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $357,748 - $417,299	-5,514 Reduced 32.5%	11,453 $811,000
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $69,780 - $85,070	-958 Reduced 5.34%	16,967 $1.28 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $181,788 - $213,393	2,555 Added 16.62%	17,925 $1.28 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $1.11 Million - $1.31 Million	15,370	15,370 $1.25 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Account

Aviance Capital Partners, LLC Gilead Sciences, Inc. Transaction History